Clinical Trial Update: Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Pegasys and Peg-Intron for chronic hepatitis C genotype 4 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PEG Intron (pegylated interferon alfa-2b)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Amr Hafez | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED